COEPTIS THERAPEUTICS HOLDING (COEP) Stock Balance Sheet
NASDAQ:COEP - Nasdaq - US19207A2078 - Common Stock - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-4-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 1.47M | 3.79M | 2.18M | 910.00K | 0.00 | |||
| Cash Equivalents | N/A | N/A | N/A | 6.40K | N/A | |||
| Receivables | 3.54M | 8.10K | 0.00 | N/A | N/A | |||
| Inventories | N/A | N/A | 0.00 | N/A | N/A | |||
| Other Current Assets | 241.60K | 142.40K | 10.00K | 50.00K | N/A | |||
| Total Current Assets | 5.25M | 3.94M | 2.18M | 6.40K | 0.00 | |||
| Non-Current Assets | ||||||||
| PPE Net | 108.90K | 71.50K | 31.90K | N/A | N/A | |||
| Investments And Advances | N/A | N/A | 75.76M | 75.75M | N/A | |||
| Intangibles | N/A | N/A | 4.55M | N/A | N/A | |||
| Other Non-Current Assets | 2.71M | 3.90M | 0.00 | 0.00 | 170.00K | |||
| Total Non-Current Assets | 2.82M | 3.97M | 4.59M | 0.00 | N/A | |||
| TOTAL ASSETS | 8.07M | 7.92M | 6.77M | 6.40K | 0.00 | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 45.00K | 0.00 | |||
| Current Portion Of LT Debt. | 975.00K | 1.50M | 2.42M | N/A | N/A | |||
| Accrued Expenses | 594.00K | 223.60K | 213.90K | 6.00K | 0.00 | |||
| Accounts Payable | 1.42M | 99.00K | 134.10K | 0.00 | 0.00 | |||
| Other Current Liabilities | N/A | N/A | 0.00 | N/A | N/A | |||
| Total Current Liabilities | 2.99M | 1.82M | 2.76M | 51.00K | 160.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 150.00K | 150.00K | 1.65M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 618.40K | 1.14M | 0.00 | 22.95M | 0.00 | |||
| Total Non-Current Liabilities | 768.40K | 1.29M | 1.65M | 0.00 | N/A | |||
| TOTAL LIABILITIES | 3.76M | 3.11M | 4.41M | 51.00K | 0.00 | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -87.36M | -65.74M | -27.55M | -590.40K | -100.00 | |||
| Additional Paid In Capital | 91.67M | 70.54M | 30.14M | 545.50K | -25.00K | |||
| Common Shares | 3.50K | 2.00K | 3.60K | 200.00 | 25.10K | |||
| Treasury Stock | N/A | N/A | -247.20K | N/A | N/A | |||
| Shares Outstanding | 1.99M | 978.30K | 468.80K | 468.80K | 1.25M | |||
| Tangible Book Value per Share | 0.12 | 0.25 | -4.70 | -0.03 | -0.00 | |||
| Total Shareholders' Equity | 4.31M | 4.80M | 2.35M | -44.70K | 0.00 | |||
| TOTAL LIABILITIES AND EQUITY | 8.07M | 7.92M | 6.77M | 6.40K | 0.00 | |||
| Statistics | ||||||||
| Debt/Equity | 0.03 | 0.03 | 0.70 | N/A | N/A | |||
| Current Ratio | 1.76 | 2.16 | 0.79 | 0.13 | N/A | |||
| Return On Assets (ROA) | -263.49% | -474.68% | -198.79% | -9015.63% | N/A | |||
| Return On Equity (ROE) | -492.96% | -782.26% | -572.16% | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21